Lv53
1120 积分 2025-10-22 加入
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
4天前
已完结
Artificial intelligence in therapeutic antibody design: Advances and future prospects
2个月前
已完结
DOTAD: A Database of Therapeutic Antibody Developability
4个月前
已完结
The complex patent situation regarding antibody Fc engineering
7个月前
已完结
Research trends in the use of nanobodies for cancer therapy
10个月前
已完结
Nanobody-based drug delivery systems for cancer therapy
10个月前
已完结
Co-delivery of PDL1-blocking scFv and chemotherapeutics using engineered exosomes for cancer therapy
11个月前
已完结
Characterization of Anti-CD3 Antibodies in Clinically Available Bispecific T Cell Engagers
11个月前
已完结
Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy
11个月前
已完结
皖公网安备34019202002308
